Summary
- Current Price
- As of today, PFE price is $26.64, down -1.53% in the most recent trading session on
- Current Price All-Time High
- PFE price is currently -56.84% below its historical high of $61.71 set on
- Market Cap
- PFE current market cap is $152B, up +8.64% over the past 365 days
- PE Ratio
- PFE current PE ratio is 35.27
- Revenue
- PFE current annual revenue is $62.58B, down -1.65% year-over-year
- Next Earnings
- The next earnings release for PFE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Pfizer Inc. |
| Ticker | NYSE: PFE |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | pfizer.com |
| Employees | 81,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $26.64 | |
| Price, 1D Change | -1.53% | |
| Market Cap | $152B | |
| TTM Dividend Yield | 6.46% | |
| PE Ratio | 35.27 | |
| Beta | 0.30 | |
| Revenue | $62.58B | |
| Revenue, 1Y Change | -1.65% | |
| EPS | $1.36 | |
| EPS, 1Y Change | -3.63% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.43 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 527:500 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $1.36 | |
| EPS Estimate | $2.97 | N/A |
| EPS Est. Change | +119.02% | N/A |
| Revenue | $62.58B | |
| Revenue Estimate | $62.14B | N/A |
| Revenue Est. Change | -0.71% | N/A |
| Current Price | $26.64 | |
| Price Target | $28.00 | - |
| Price Tgt. Change | +5.12% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.93 | $1.41 | -51.90% | |
| $3.12 | $1.36 | -56.59% | |
| $2.97 | N/A | +119.02% | |
| $2.88 | N/A | +112.51% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $63.08B | $63.63B | +0.86% | |
| $61.89B | $62.58B | +1.11% | |
| $62.14B | N/A | -0.71% | |
| $59.76B | N/A | -4.50% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +8.36% | |
| Price, 3Y | -26.10% | |
| Market Cap, 1Y | +8.64% | |
| Market Cap, 3Y | -25.38% | |
| Revenue, 1Y | -1.65% | |
| Revenue, 3Y | -37.63% | |
| EPS, 1Y | -3.63% | |
| EPS, 3Y | -75.22% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $26.64 | |
| SMA 200 | $25.88 | |
| SMA 50 | $25.09 | |
| EMA 200 | $25.70 | |
| EMA 50 | $25.32 | |
| MACD | $0.42 | |
| Beta | 0.30 | |
| ATR | $0.55 | |
| 14-Day RSI | 72.80 | |
| 10-Day Volatility | 17.47% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.43 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 6.46% | |
| Total Dividend | $1.72 | |
| Dividends Paid | $9.77B | |
| Payout Ratio | 125.48% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $62.58B | |
| EPS | $1.36 | |
| Gross Profit | $46.51B | |
| Gross Margin | 74.33% | |
| Operating Income | $17.41B | |
| Operating Margin | 27.82% | |
| Net Income | $7.79B | |
| Net Margin | 12.44% | |
| EBITDA | $23.70B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.78 | |
| Current Ratio | 1.16 | |
| Quick Ratio | 0.87 | |
| - | ||
| Piotroski F-Score | - | |
| Altman Z-Score | 2.13 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $86.48B | |
| Cash & Equivalents | $13.60B | |
| Total Assets | $208.16B | |
| Current Assets | $42.90B | |
| Total Liabilities | $121.39B | |
| Current Liabilities | $36.98B | |
| Total Debt | $67.42B | |
| Short Term Debt | $3.48B | |
| Accounts Payable | $5.24B |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $54.83B | |
| Operating Expenses | $29.11B | |
| Cost Of Goods Sold | $16.07B | |
| SG&A | $0.00 | |
| D&A | $6.59B | |
| Interest Expense | $0.00 | |
| Income Tax | -$266.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $11.71B | |
| CFI | -$1.35B | |
| CFF | -$10.30B | |
| Capex | $2.63B | |
| Free Cash Flow | $9.08B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Guggenheim | → | |
| Guggenheim | → | |
| BMO Capital | → | |
| B of A Securities | → | |
| JP Morgan | → | |
| HSBC | → | |
| Cantor Fitzgerald | → | |
| RBC Capital | → | |
| Citigroup | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with PFE
FAQ
- What is the ticker symbol for Pfizer Inc.?
- The ticker symbol for Pfizer Inc. is NYSE:PFE
- Does Pfizer Inc. pay dividends?
- Yes, Pfizer Inc. pays dividends. The last payment was $0.43, with an ex-dividend date on July 24, 2026
- What sector is Pfizer Inc. in?
- Pfizer Inc. is in the Healthcare sector
- What industry is Pfizer Inc. in?
- Pfizer Inc. is in the General Drug Manufacturers industry
- What country is Pfizer Inc. based in?
- Pfizer Inc. is headquartered in United States
- When did Pfizer Inc. go public?
- Pfizer Inc. initial public offering (IPO) was on June 1, 1972
- Is Pfizer Inc. in the S&P 500?
- Yes, Pfizer Inc. is included in the S&P 500 index
- Is Pfizer Inc. in the NASDAQ 100?
- No, Pfizer Inc. is not included in the NASDAQ 100 index
- Is Pfizer Inc. in the Dow Jones?
- No, Pfizer Inc. is not included in the Dow Jones index
- When was Pfizer Inc. last earnings report?
- Pfizer Inc.'s most recent earnings report was on August 4, 2026
- When does Pfizer Inc. report earnings?
- The next expected earnings date for Pfizer Inc. is November 3, 2026
Data Sources & References
- PFE Official Website www.pfizer.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/78003/000007800326000005/0000078003-26-000005-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- PFE Profile on Yahoo Finance finance.yahoo.com/quote/PFE
- PFE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pfe
